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Abstract
Background: Substituted judgment asks the proxy to decide what the patient would have decided, had he or she
been competent. It is unclear whether substituted judgment of the patient’s quality of life can serve as a surrogate
measure in patients with dementia.
Methods: 212 patients with dementia and their proxies were interviewed in their homes. Dementia syndrome was
characterized with cognitive, non-cognitive and functional scales. Quality of life (QoL) was assessed with the
QoL-AD.
Results: Substituted judgment of the patient’s QoL was unrelated to dementia severity but also correlated with
the proxie’s own QoL (r = 0.356; p < 0.001). Gender-specific analysis reveals that for male proxies the most
important variable is severity of patient’s depression (r = -0.895; p = 0.001) while for female proxies it is the proxie’s
own QoL (r = 0.371; p < 0.001). Subjective burden correlates with the proxie’s QoL in females (r = -0.282; p =
0.001) but not in males (r = -0.163, p = 0.161).
Conclusion: Substituted judgment of the patient’s QoL does not correlate with dementia severity. Substituted
judgment is subject to proxy-related variables in a gender-dependent fashion and therefore not suited to serve as
an appropriate surrogate of the patients’ quality of life.
Background
Alzheimer’s disease (AD) is a neurodegenerative disease
with increasing prevalence in the aging societies of the
Western hemisphere. Similarly, the prevalence of other
age-related diseases increases. For all these diseases and
conditions therapeutic interventions are being developed
and improved. Common outcome variables are requested
by today’s health care systems to allow a comparison of
the impact of diseases and the efficacy of treatments.
One widely considered option to analyze the impact of
disease on patients’ life is to evaluate “Quality of life”
(QoL).
The World Health Organisation defines QoL as “the
individual’s perceptions of their position in life in the
context of the culture and value systems in which they
live, and in relationship to their goals, expectations, and
standards” (WHO-QoL, 1995). By this definition QoL is
a subjective construct, being evaluated by the affected
person by means of self reports. A widely used model
assumes four domains which contribute to the indivi-
dual’s QoL: behavioural competence, psychological well-
being, objective environment, and self-perceived QoL [1].
Hence, it is widely accepted that QoL is a multidimen-
sional construct containing both subjective and objective
elements, such as perceived contentment and functional
abilities, respectively. Intuitively, one would assume, that
dementia severity is inversely correlated with the self
assessed Quality of life of the patient. However, the bur-
den imposed by disease may be perceived differently in
varying stages of disease which could result in a bi- or
multimodal distribution of perceived quality of life over
different stages of disease severity. Indeed, the validity of
self-assessment of quality of life in dementia patients has
recently been questioned [2-4].
Compared with their proxies, patients in early stages of
dementia are likely to give overly optimistic ratings of
their own mental capacities, lost functions, activities and
social relationships [5]. Therefore clinicians and clinical
investigators often rely on external evaluation of the
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substitute.
Substituted decision making for patients who lack
capacity, however, is a much-discussed topic. Substituted
judgment implies that the substitute for the incompetent
patient is the decision given by proxy considering what
the patient would have decided, had he or she been com-
petent [6]. However, agreement between the patient’s
and the substitute’s decision in several studies has shown
to be mediocre at best, and it has been debated whether
substituted judgment is an adequate surrogate for the
patient’s decisions [7,8]. Discussion between patient and
proxy has been found to facilitate more accurate substi-
tuted judgment regarding the preferences of patients for
life-sustaining therapies [8]. Overall, the accuracy of sub-
stituted judgments is subject to the kind of scenario to be
decided, the amount of discussion between patient and
surrogate and multiple clinically apparent patient- and
proxy-related factors [9].
Dementia results in impaired cognition, language,
insight, and judgment, and other behavioural and psycho-
logical symptoms of dementia (BPSD). Therefore, proxies
often make decisions on the patient’s behalf. Proxies are
even used as informants in clinical studies on therapeutic
efficacy. This assumes that proxies describe the patient’s
behaviour and well-being in an objective and reliable
fashion. Theoretically, the proxy should be able to know
the preferences of the patient, considering that dementia
often extends over a long time giving proxy and patient
plenty of time to discuss preferences. Empirically, how-
ever, proxy-ratings of QoL in AD patients does not corre-
late well with the patients’ own answers, challenging the
validity of the reported answers by the caregivers [10-12].
In the present study in patients’ and proxies’ homes,
the proxy was asked to rate the QoL of the patient as a
substituted judgment, i.e. how the patient would assess
his or her own QoL should he or she be competent. It
was the goal to analyze whether substituted judgment of
the patients’ quality of life can serve as a surrogate mea-
sure of the patients’ q u a l i t yo fl i f eo rw h e t h e ri ti s
modulated by proxy-related variables.
Methods
The study was performed according to institutional
guidelines and the principles laid out in the Declaration
of Helsinki. All patients and proxies gave their written
consent to participate in this study.
Patients and Caregivers
The patients and their proxies were recruited from a
cohort of patients interested in or applying for a short-
term in-patient treatment at the Alzheimer Therapy cen-
tre Bad Aibling. Most of the dyads applying were spouse
dyads (see below) which limits the generalizability of the
study. There may be other recruitment biases involved
but the nature of the study did not allow the systematic
control of other possible biases. It can be ruled out, how-
ever, that these patients represent a selection of persons
with acute behavioural and psychological symptoms of
dementia, as the time between application for short-term
rehabilitation and approval by the health insurance takes
several weeks on average. Initial contact and screening of
eligibility to take part in the study were made via tele-
p h o n eb yas t u d yn u r s e .C r i t e r i af o ri n c l u s i o ni nt h e
study were a diagnosis of dementia of a mixed or Alzhei-
mers type performed by a general practitioner or neurol-
ogist/psychiatrist. Only patients living in one household
with their primary proxy were included in the study. The
primary proxy was the spouse in 180 of 194 dyads (93%).
This predominance of spouse dyads limits the generaliz-
ability of the study to dyads with other patient-proxy
relations.
Baseline assessment was performed between Septem-
ber 2008 and June 2010 with a MMSE score of 3 and
above. Figure 1 shows the flow chart of the study
cohort.
The remaining sample comprises 194 patients with
either AD or mixed dementia (mean age 73.0 ± 7.1 years,
range 52 - 89 years; 70,6% male) and their proxies (mean
age 69.0 ± 7.7 years, range 43 - 90 years; 27.8% male).
MMSE scores ranged from 3 - 28 (mean 17.3 ± 6.8).
All interviews took place in the domestic surroundings
of these families after explaining the aim of the study and
obtaining informed consent by both the patient and the
proxy. Assessments were carried out by specially trained
research assistants. Patients and proxies were interviewed
separately to minimize bias and mutual influence on the
responses.
Nomenclature
In order to make clear who the person was that performed
the scale/questionnaire and whom that person rated we
used the following nomenclature: rater(measure)rated per-
son. For example: proxy(QoL-AD substituted)patient
means that the proxy rated the patient’sQ o La st h e
patient would have done, and proxy(QoL-AD)proxy sig-
nifies that the proxy rated his or her own QoL.
Assessments
Mini-Mental Status Examination (MMSE [13])
The MMSE is the most commonly used instrument to
stage the severity of dementia by assessing cognitive
functions. It comprises tests on orientation, registration,
short-term memory, language use, comprehension, and
basic motor skills. Scores range from 0 - 30. Commonly,
the scores on the Mini-Mental Status Examination are
used to describe the severity of dementia. Patients are
considered to be in mild stages of disease when scoring
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when scoring between 10 and 19, and severe when scor-
ing 9 or less. The test was administered to patients, only.
Behavioural pathology in Alzheimer’s Disease Rating Scale
(Behave-AD [14])
The Behave-AD is a clinical rating instrument to charac-
terize the phenomenology of behavioural symptoms. It
comprises 25 items, all of which are answered by the
proxy. The test was administered to proxies, only, to char-
acterize behavioural symptoms of the patients (proxy
(Behave-AD)patient).
Geriatric Depression Scale (GDS [15])
The Geriatric Depression scale uses a 15-item question-
naire to assess symptoms ofd e p r e s s i o na n dh a sb e e n
validated in the cognitively intact and the demented
elderly [16,17]. The test was administered to both,
patients and proxies (proxy(GDS)proxy and patient
(GDS)patient, respectively).
Activities of Daily living (B-ADL [18])
This scale is used to assess the deficits in the perfor-
mance of the patients’ everyday activities. It comprises
25 items, all of which are answered by the proxy. Rat-
ings are made on a 10-point Likert-type scale. The test
was administered to proxies, only, to characterize activ-
ities of daily living of the patients (proxy(B-ADL)
patient).
Instrumental Activities of Daily living (iADL [19])
This scale is used to assess the deficits in the performance
of the patients’ instrumental activities of daily living. It
comprises 8 items with lower scores indicating worse per-
formance in activities. The test was administered to
proxies, only, to characterize instrumental activities of
daily living in the patients (proxy(iADL)patient).
Euro-QoL (EQ-5D [20])
The EQ-5D questionnaire is a generic instrument to
measure health related QoL in five domains: mobility,
self-care, usual activities, pain/discomfort and anxiety/
depression. It can be applied to patients as well as used
in proxies to rate their own and the patients’ QoL
[21,22]. There are two core components of this instru-
ment: a description of the respondents own health in the
above mentioned five domains (rated on a three point
Likert scale each) and a rating of their overall own health
on a visual analogue scale (VAS, score 0 - 100). In order
to capture the cognitive deterioration, a cognitive dimen-
sion was added (EQ-5D+C). The test was administered to
both, proxies and patients. In this manuscript we only
analyzed the EQ-5D VAS of the proxy (proxy(EQ-5D
VAS)proxy).
Quality of Life in Alzheimer’s disease (QoL-AD)[23]
The QOL-AD is a 13-item questionnaire on Quality of
life and can be used both in patients with dementia [24]
Figure 1 Flow chart of the study cohort.
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ers the following domains: physical health, energy,
mood, living situation, memory, family, marriage,
friends, chores, fun, money, self and life as a whole. The
QoL-AD is structured in a four-choice format, ranging
from 1 being poor and 4 being excellent and refers to
the patient’s current QoL. Possible scores range from
13-52 with higher scores indicating better QoL. In this
study we administered the scale to the caregiver to mea-
sure their own QoL (proxy(QoL-AD)proxy), as well as
the patients’ QoL via substituted judgment (proxy(QoL-
AD substituted)patient). A substituted judgment asks
the caregiver to rate how they think the patient views
his or her own QoL. Subsequent to reading each item
the proxy was reminded to provide the answer that he
or she thinks the patient would give.
Frequency of medication use
The proxy was asked about the daily intake of medication
by himself or herself and about the frequency of the
patient with a fourfold choice (1: no medication use; 2: 1
to 3 times; 3: 4 to 6 times; 4: more than 6 times). Funding
of the study did not allow to assess symptoms of neurop-
sychiatric disease or multimorbidity in the proxies in
detail. However, when designing the study we aimed at
having at least one indirect measure of multimorbidity in
patients and proxies and used frequency of medication use
as a surrogate of multimorbidity.
Data Analysis
All statistical analyses for the investigation of group dif-
ferences were carried out using the statistics program
SPSS (SPSS 15.0 for Windows, Chicago, Ill., 2001).
Results
Quality of life - the caregiver’s self-assessment (proxy
(QoL-AD)proxy)
Not surprisingly, less behavioural symptoms of the
patients are associated with higher scores in the proxy
(QoL-AD)proxy scale (proxy(Behave-AD)patient: r =
-0.278; p < 0.001). Moreover, the score of the proxy(QoL-
AD)proxy is correlated with his or her self-assessed mood
(proxy(GDS)proxy: r = -0.635; p < 0.001) and his or her
self-reported overall health (proxy(EQ-5D VAS)proxy: r =
0.459; p < 0.001).
To get further insight into the caregiver’s variables we
performed a gender-specific analysis. Severity of the
patient’s dementia was alike for male and female care-
givers (MMSE 17.37 ± 6.56 and 17.10 ± 6.89, respectively,
p = 0.800). Gender-specific analysis reveals that mood and
overall health correlate with the proxy(QoL-AD)proxy
s c o r ei nb o t hm a l ea n df e m a l ec a r e g i v e r s( p r o x y ( G D S )
proxy: males: r = -0.528, p < 0.001; females: r = -0.646, p <
0.001 and proxy(EQ-5D VAS)proxy: males: r = 0.288, p =
0.035; females: r = 0.471, p < 0.001). Despite the overall
association of mood with the proxy(QoL-AD)proxy score
in both males and females, depression itself is gender-
dependent (proxy(GDS)proxy: males: 2.66 ± 2.60, females:
3.91 ± 2.84, p = 0.005). Subjective QoL of the caregiver
(proxy(QoL-AD)proxy) is associated with functional
assessment of the patient by the caregiver, although only
in female caregivers (females: r = -0.241, p = 0.004; males:
r = -0.157, p = 0.258). The burden experienced by the
proxy was slightly higher in females than in males (2.14 ±
0.87 vs. 1.81 ± 1.03, respectively, p = 0.046). The burden
correlates with the proxy(QoL-AD)proxy score in females
(r = -0.282; p = 0.001) but not in males (r = -0.163, p =
0.161). Data are displayed in Table 1.
Quality of life - substituted judgment (proxy(QoL-AD
substituted)patient)
The proxy was asked to rate the QoL of the patient as a
substituted judgment (proxy(QoL-AD substituted)
Table 1 Gender-specific analysis of patient and proxy-
related variables grouped according to sex of the proxy
male proxies female proxies
n = 54 n = 140
Proxy-related variables
Age mean 72.43 67.63
SD 6.64 7.67
t-test p < 0.001
proxy(GDS)proxy mean 2.66 3.91
SD 2.60 2.84
t-test p = 0.005
proxy(QoL-AD)proxy mean 38.35 35.95
SD 4.31 5.36
t-test p = 0.002
Patient’s self report
Age patient mean 71.70 73.52
SD 6.66 7.20
t-test p = 0.099
MMSE mean 17.37 17.10
SD 6.56 6.89
t-test p = 0.800
patient(GDS)patient mean 3.09 2.84
SD 3.19 2.60
t-test p = 0.605
Proxie’s report about patient
proxy(Behave-AD)patient Mean 5.22 6.44
SD 4.88 4.76
t-test p = 0.121
proxy(B-ADL)patient Mean 7.00 7.68
SD 2.67 2.04
t-test p = 0.100
proxy(iADL)patient Mean 3.39 2.50
SD 2.52 1.87
t-test p = 0.021
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own QoL would he or she be competent. Similar results
as in the self-assessment were obtained for the scores of
the substituted judgment (proxy(QoL-AD substituted)
patient): (proxy(Behave-AD)patient: r = -0.308; p <
0.001); (proxy(GDS)proxy: r = -0.299; p < 0.001); (proxy
(EQ-5D VAS)proxy: r = -0.203; p < 0.001). Spearman’s
rho for the correlation between proxy(QoL-AD)proxy
and proxy(QoL-AD substituted)patient ranged from
-0,005 and 0,490 for the individual items of the QoL-
AD scale, indicating that the proxy judged differently
when asked about himself or herself and asked to serve
as a substitute of the patient (Table 2).
Commonly, severity of dementia is staged according to
the score in the MMSE (mild: MMSE score ≥ 20; moder-
ate: 10 ≤ MMSE score ≤ 20; severe: 3 ≤ MMSE score ≤
9). The proxy(QoL-AD substituted)patient score was
unrelated to severity of dementia (Table 3).
To analyze which variables related to the severity of the
disease of the patient, or which caregiver-related variables
relate to the substituted judgment on the quality of life of
the patient by the proxy (proxy(QoL-AD substituted)
patient), we performed a stepwise regression analysis. As
independent variables characterizing the severity of the
disease of the patient we used the total scores of the
MMSE, the patient(GDS)patient, the proxy(Behave-AD)
patient, the proxy(B-ADL)patient, the proxy(iADL)
patient, and the frequency of drug use of the patient. As
variables characterizing the well-being and health of the
proxy, we used the total score of the proxy(EQ-5D VAS)
proxy and the proxy(QoL-AD)proxy. Both age of the
patient and age of the proxy were included as indepen-
dent variables in the analysis. The most important vari-
ables contributing to the caregivers’ substituted judgment
of the patients’ QoL (proxy(QoL-AD substituted)patient)
Table 2 Correlation between proxy(QoL-AD)proxy and
proxy(QoL-AD substituted)patient for the individual
items.
Individual Items Qol-AD Spearman’s rho p
Physical Health 0.137 0.085
Energy 0.185 0.010*
Mood 0.146 0.042*
Living situation 0.159 0.027*
Memory -0.005 0.948
Family 0.477 < 0.001*
Marriage 0.490 < 0.001*
Friends 0.477 < 0.001*
Self 0.095 0.187
Household chores 0.074 0.305
Do things for fun 0.219 0.002*
Money 0.405 < 0.001*
Life as a whole 0.250 < 0.001*
Table 3 Patient and proxy-related variables grouped
according to severity of dementia
mild moderate severe
Patient-related variables
N8 1 8 3 3 0
Age patient Mean 72.91 73.24 72.67
SD 7.06 7.07 7.41
one-way
ANOVA
p = 0.918
MMSE Mean 23.67 14.87 6.03
SD 2.48 2.83 2.25
one-way
ANOVA
p < 0.001
Patient’s self report
proxy(GDS)proxy Mean 2.93 2.99 2.63
SD 2.94 2.77 2.31
one-way
ANOVA
p = 0.844
Proxy-related variables
Age proxy Mean 68.86 69.40 68.03
SD 8.00 7.58 7.26
one-way
ANOVA
p = 0.701
proxy(QoL-AD)proxy Mean 36.68 36.72 36.17
SD 4.99 5.93 3.35
one-way
ANOVA
p = 0.874
proxy(GDS)proxy Mean 3.35 3.70 3.80
SD 2.77 2.85 2.95
one-way
ANOVA
p = 0.649
Proxie’s report about
patient
proxy(Behave-AD)patient Mean 4.68 7.04 7.33
SD 4.46 4.59 5.47
one-way
ANOVA
p = 0.002
proxy(B-ADL)patient Mean 6.36 8.19 8.57
SD 2.49 1.69 1.49
one-way
ANOVA
p < 0.001
proxy(iADL)patient Mean 3.93 2.00 1.63
SD 2.38 1.27 1.59
one-way
ANOVA
p < 0.001
Proxie’s substituted report
proxy(QoL-AD substituted)
patient
Mean 33.58 33.25 32.67
SD 5.07 6.39 5.28
one-way
ANOVA
p = 0.752
Mini-Mental Status Examination [13] (MMSE; mild: MMSE ≥ 20; moderate: 10 ≥
MMSE ≤ 19; severe:
MMSE ≤ 9) of the patient. GDS: Geriatric Depression Scale; QoL-AD: Quality of
Life in Alzheimer’s
disease; Behave-AD: Behavioral pathology in Alzheimer’s Disease Rating Scale
[14]; B-ADL:Activities
of Daily living scale [18]; iADL: Instrumental Activities of Daily living [19]
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caregiver (proxy(QOL-AD)proxy), and neuropsychiatric
symptoms of the patient. In the whole group as well as in
the group with male or female proxies, these three vari-
ables explain about one third of the variance of substi-
tuted QoL-appraisal by the proxy. Data are displayed in
Table 4.
Factor analysis of QoL-AD substituted judgment (proxy
(QoL-AD substituted)patient)
To compare the dimensions of importance in answering
the QoL-AD questionnaire when proxies report for
themselves (proxy(QoL-AD)proxy), and when they per-
form substituted judgment (proxy(QoL-AD substituted)
patient) a factor analysis was performed with a principal
factor analysis of the QoL-AD item-level data, using an
Oblimin-direct rotation with eigenvalues greater than 1
to sufficiently consider partial correlation between fac-
tors [26]. All analyses (total group, male proxies, and
female proxies) had a Kaiser-Meyer-Olkin (KMO)
measure between 0.8 and 0.9 exceeding the size of 0.5
or greater recommended for meaningful factor analysis
[26]. For interpretation of the rotated factors, salient
loadings were defined as values greater or equal to 0.5;
in cases where an item did not have a loading of 0.5 or
greater, its highest loading was selected to define its
position in the factor structure.
Overall, the factor structure for self-assessment and for
substituted judgment resembles these mutually within
the whole group as well as the gender specific subgroups.
Item “money” is somewhat important in the proxies’ self
assessment (proxy(QoL-AD)proxy)but is of no sigificance
in the substituted judgment (proxy(QoL-AD substituted)
patient). Similarly, item “memory” is of some importance
in the proxies’ self assessment (proxy(QoL-AD)proxy but
less so in the substituted judgment(proxy(QoL-AD sub-
stituted)patient). General health is of similar importance
in the whole group and for both males and females. In
t h em a l ep r o x i e s ’ substituted judgment (proxy(QoL-AD
substituted)patient) this comprises “household chores”
Table 4 Stepwise regression of substituted judgment of the patients’ QoL (proxy(QoL-AD substituted)patient).
R
2 degrees of
freedom
change in
F
overall
significance
Regression
coefficient
T significance
All proxies
0.127 1,192 27.946 p < 0.001 proxy(QoL-AD)proxy 0.390 5.286 p < 0.001
0.213 1,191 20.822 p < 0.001 proxy(QoL-AD)proxy 0.373 5.299 p < 0.001
patient(GDS)patient -0.608 -4.563 p < 0.001
0.290 1,190 20.632 p < 0.001 proxy(QoL-AD)proxy 0.313 4.581 p < 0.001
patient(GDS)patient -0.582 -4.583 p < 0.001
proxy(Behave-AD)
patient
-0.335 -4.542 p < 0.001
Male Proxies
0.200 1,52 12.962 p = 0.001 patient(GDS)patient -0.895 -3.600 p = 0.001
0.377 1,51 14.515 p < 0.001 patient(GDS)patient -0.940 -4.241 p < 0.001
proxy(QoL-AD)proxy 0.618 3.810 p < 0.001
0.441 1,50 5.710 p = 0.021 patient(GDS)patient -0.864 -4.026 p < 0.001
proxy(QoL-AD)proxy 0.559 3.556 p = 0.001
proxy(Behave-AD)patient -0.335 -2.390 p = 0.021
Female
proxies
0.134 1,138 21.382 p < 0.001 proxy(QoL-AD)proxy 0.371 4.624 p < 0.001
0.218 1,137 14.736 p < 0.001 proxy(QoL-AD)proxy 0.315 4.043 p < 0.001
proxy(Behave-AD)
patient
-0.337 -3.839 p < 0.001
0.258 1,136 7.286 p = 0.008 proxy(QoL-AD)proxy 0.293 3.821 p < 0.001
proxy(Behave-AD)
patient
-0.337 -3.921 p < 0.001
patient(GDS)patient -0.423 -2.699 p = 0.008
0.293 1,135 6.622 p = 0.011 proxy(QoL-AD)proxy 0.290 3.864 p < 0.001
proxy(Behave-AD)
patient
-0.335 -3.988 p < 0.001
patient(GDS)patient -0.399 -2.593 p = 0.011
Age proxy 0.132 2.573 p = 0.011
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rate factor in the female proxies’ substituted judgment
(proxy(QoL-AD substituted)patient). Moreover, “mar-
riage” is a separate factor in the male proxies’ substituted
judgment (proxy(QoL-AD substituted)patient), whilst in
t h ef e m a l ep r o x i e s ’ judgment (proxy(QoL-AD substi-
tuted)patient) it is combined with item “family” and “life
as a whole”. Results of the factor analysis of the proxies
self-judgment on their QoL are shown in Table 5, results
for proxies’ substituted judgment of patients’ QoL are
shown in Table 6.
Discussion
Patients and proxies
Similar to other reports in the literature [27], the male
proxies of dementia patients who sought help were
older than their female counterparts applying for short-
term rehabilitation. However the age of the patient
cared for was not gender-specifically different.
Depression is a frequent symptom in caregivers of
persons with dementia [28,29]. Similar to previous stu-
dies [30,31] we have found a higher score of depres-
sion in female proxies compared to male proxies. It is
beyond the scope of the present manuscript to analyze
modulator variables in detail. It is known however,
that the well-being and mood of informants may
impose a bias on the results obtained with subjective
r a t i n g ss u c ha sA D L sa n di A D L s[ 3 2 , 3 3 ] .I tw a st h e
primary goal of the present manuscript to analyze sub-
stituted QoL judgment and its modulation by caregiver
characteristics. Correlational analysis for the single
items of the QoL-AD when answered by the proxy for
both, himself and herself as well as when answered as
as u b s t i t u t ef o rt h ep a t i e n tc l e a r l ys h o w st h a tp r o x i e s
indeed rated differently when answering for themselves
and the patient.
Proxy-self judgment of the proxie’s QoL (proxy(QoL-AD)
proxy)
T h es e l f - a s s e s s e dq u a l i t yo fl i f eo ft h ep r o x y( p r o x y
(QoL-AD)proxy) in the present study was unrelated to
severity of dementia. With advancing dementia severity,
not only cognitive functions deteriorate but the preva-
lence and severity of behavioural and psychological
symptoms of dementia (BPSD) increase, e.g. agitation.
Previous studies reported that these symptoms are sig-
nificantly associated with caregiver assessment of the
patient’s QoL but not with patients’ self-assessed QoL
[34,35]. Univariate analysis of BPSD and the proxies’
QoL using a different scale for assessment of BPSD, the
Behave-AD, yields a clear-cut association of caregiver
QoL (proxy(QoL-AD)proxy) and behavioural symptoms
of dementia patients. Likewise, QoL of caregivers (proxy
(QoL-AD)proxy) is inversely correlated with decline of
basic and instrumental activities of daily living. As
expected, there is an association between QoL (proxy
(QoL-AD)proxy) in female proxies and the subjective
burden imposed by caring for a patient with dementia.
However, this association was not found in males. The
reasons for this gender-dependency remains elusive on
grounds of the current data and needs to be addressed
in future studies.
Similar to a previous study [36], depression is higher
in female than in male caregivers and the subjective
QoL (proxy(QoL-AD)proxy) is worse. Considering simi-
lar cognitive impairment and behavioural symptoms in
the respective patients, this argues for gender-dependent
variables on the proxies’ side which cause the differing
Table 5 Factor-analysis for self-judgment of QoL (proxy(QoL-AD)proxy) in proxies
All proxies - proxy(QoL-AD)proxy Male proxies - proxy(QoL-AD)proxy Female proxies - proxy(QoL-AD)proxy
Factor Factor Factor
1 2 3 1 2 3 4 5 123
Physical Health ,519 ,776 ,499
Energy ,566 ,589 ,494
Mood ,727 ,605 ,735
Living situation ,718 ,508 ,710
Memory ,429 ,853 ,460
Family ,457 ,418 ,688
Marriage ,492 ,404
Friends ,436 ,585
Self ,815 ,663 ,713
Household chores ,435 -,586 ,466
Do things for fun ,424 ,770 ,416
Money ,480 ,708
Life as a whole ,721 ,811 ,834
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imposed by the stress of caregiving.
Substituted judgment of the patient’s QoL (proxy(QoL-AD
substituted)patient)
Patients’ self assessment of their own qualiy of life (EQ-
5D+C) is impaired even in mild stages of dementia
[2,3,37]. Likewise, assessment of the quality of life by the
proxy is under discussion [2,12,32,38]. In a previous
study, caregiver’s judgement of the patient’sQ o Lw a s
associated with the severity of the patient’s neuropsychia-
tric symptoms in general and depressive symptoms in
particular [34]. Moreover, dementia severity and the
caregiver’s depressive mood negatively affect the care-
givers’ assessments of the patient’s QoL [12]. One possi-
ble alternative to be considered beyond staging disease
severity and disease impact with medical outcome vari-
ables, is to instruct the proxy to assume the role of the
patient cared for, and to give the appraisal that the
patient would have given hadhe or she been competent
to do so - substituted judgment. Until now, little is
known about substituted judgment on the patients’ QoL
in patients with dementia.
The present analysis reveals that substituted judgment
of the patients’ QoL (proxy(QoL-AD substituted)patient)
is modulated by proxy-related variables in a gender-
dependent fashion. The stepwise regression analysis per-
formed in this study shows that substituted judgment
(proxy(QoL-AD substituted)patient) is subject to the self-
assessed depressive mood of the patient (patient(GDS)
patient), the proxies’ assessment of behavioural symp-
toms of the patient and the subjective QoL of the proxy
(proxy(QoL-AD)proxy). In a gender-specific analysis,
subjective QoL of the proxy (proxy(QoL-AD)proxy) is
the most important variable influencing female caregivers
while it is the depression of the patient in male
caregivers.
Similarly, gender-dependent aspects were found in a
factorial analysis of the QoL-AD. The literature shows
t w of a c t o ra n a l y t i ca n a l y s e sf o rt h eQ o L - A D .O n ew a s
performed in patients with Alzheimer’s disease [24] and
the other in healthy elderly individuals [25]. The latter
indicated the best fit for a three-factor solution, i.e. physi-
cal, social, and psychological well-being [25]. Applying
standard factor-analytic procedures and using the Kaiser
criterion, the present study also shows the best overall fit
for a three-factor solution in proxies of patients with Alz-
heimer’s disease. Overall, there is good agreement for the
factor structure of the self-assessment of the proxies’
own QoL (proxy(QoL-AD)proxy) and the substituted
judgment of the patients’ QoL (proxy(QoL-AD substi-
tuted)patient). Gender-specific analysis, however, reveals
slight differences. Female proxies have an even greater
agreement for the factor structure judging their own QoL
(proxy(QoL-AD)proxy) and substituted judgment on the
patients’ QoL(proxy(QoL-AD substituted)patient). Male
proxies show some differences: the factor structure for
substituted judgment (proxy(QoL-AD substituted)
patient) convey factors that may be labelled as general-
and health-related, social, and marriage. In contrast,
female proxies portray a factor structure which may be
better labelled as general- and health-related, social, and
functional.
Conclusion
Substituted judgment of the patient’sQ o L( p r o x y ( Q o L -
AD substituted)patient) does not correlate with dementia
severity. Substituted judgment is subject to proxy-related
Table 6 Factor-analysis for proxies’ substituted judgment of patients’ QoL (proxy(QoL-AD substituted)patient)
All proxies - proxy(QoL-AD
substituted)patient
Male proxies - proxy(QoL-AD
substituted)patient
Female proxies - proxy(QoL-AD
substituted)patient
Factor Factor Factor
1 231231 2 3
Physical Health ,683 ,739 ,651
Energy ,535 ,840 ,549
Mood ,710 ,785 ,673
Living situation ,697 ,758 ,679
Memory ,461 ,462
Family ,488 ,563
Marriage ,505 ,817 ,542
Friends ,863
Self ,502 ,628 ,496
Household chores -,693 ,728 ,684
Do things for fun -,660 ,533 ,623
Money ,683
Life as a whole ,535 ,697 ,510 ,455
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Page 8 of 10variables in a gender-dependent fashion and is therefore
not suited to serve as an appropriate surrogate of the
patients’ quality of life. Even the proxies’ self-assessment
of their own QoL (proxy(QoL-AD)proxy) is no surrogate
for representing deterioration of the patients’ well being
in patients with dementia.
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